Navigation Links
Cardium Reports on Second Quarter 2008 Highlights and Financial Results
Date:8/11/2008

p>

Weighted average common shares

outstanding - basic and diluted 43,629,975 40,914,902

Selected Condensed Consolidated June 30, December 31,

Balance Sheet Data 2008 2007

(Unaudited) (Audited)

Cash and cash equivalents $4,138,989 $7,722,816

Accounts receivable, net 406,963 565,613

Inventories, net 1,741,439 1,037,164

Prepaid expenses and other current assets 537,124 522,067

Property and equipment, net 2,006,735 1,650,632

Patented technology and

intangibles, net 4,371,502 4,766,330

Other long-term assets 600,041 661,067

Total assets $13,802,793 $16,925,689

Current liabilities $9,602,428 $5,255,392

Long-term liabilities 96,420 3,241,992

Stockholder's equity 4,103,945 8,428,305

Total liabilities and

stockholder's equity $13,802,793 $16,925,689


'/>"/>
SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
4. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
5. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
6. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
7. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
8. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
9. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
10. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
11. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Conn., Dec. 15 Rib-X Pharmaceuticals, Inc., ... commercialization of novel drugs for the treatment of ... into a collaborative research agreement with Massachusetts General ... plan for the collaboration, Dr. David Hooper of ... an established animal model to determine resistance development ...
(Date:12/15/2009)... 15 Arlington Medical Resources (AMR) and ... (MRSA) is the most concerning pathogen to ... their treatment of skin and skin structure infections. ... top factors that influences European physician drug selection ... key factors that drive prescribing include an agent,s ...
(Date:12/15/2009)... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a ... announced today,that Weidong Yin, Chairman, President & ... to be one of 18 nominees for ... CCTV,s Economic Man-of-the-Year is the country,s ... to as the "Oscar Award of the,Chinese ...
Breaking Medicine Technology:Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 2Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 3Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 1Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 2Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 3Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 4Sudden Cardiac Arrest Foundation Mourns the Loss of Michael Jackson 50143 1Sudden Cardiac Arrest Foundation Mourns the Loss of Michael Jackson 50143 2Latin America must cut blood pressure to thrive 50141 1Latin America must cut blood pressure to thrive 50141 2Latin America must cut blood pressure to thrive 50141 3
... Oct. 18 Posit Science Corporation,announced today that ... an,innovative computerized training program designed to enhance memory. ... study has now enrolled more than five hundred ... and contribute to scientific,research. Principal Investigators for ...
... 18 Access Pharmaceuticals, Inc.,(OTC Bulletin Board: ... be,presenting clinical and preclinical data on its ... of the American Association for,Cancer Research (AACR), ... Research and Treatment of Cancer (EORTC) entitled,"International ...
Other Medicine Technology:Study Demonstrates Mindful Approach to Aging 2Study Demonstrates Mindful Approach to Aging 3Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference 2
(Date:12/15/2009)... cardiovascular event, suicide goes up within a week ... 15 (HealthDay News) -- Emotional stress can put ... for cardiovascular events and suicide, a new study ... Swedish men diagnosed with prostate cancer between 1961 ... experienced a cardiovascular event within a year of ...
(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... the U.S. and its International Trade ... http://www.reportlinker.com/p0167482/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The newly published ... provides the latest market research on ...
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... Diseases Therapeutics - Market Forecasts to ... Deals Analysis ,, ... ,, The author has released its ...
(Date:12/15/2009)... STAMFORD, Conn., Dec. 15 Aon ... of Aon Corporation (NYSE: AON ... the firm as senior vice president with ... of the national Pharmacy Practice. ,, ... her new role, Zeitel will work under ...
(Date:12/15/2009)... LAKE FOREST, Ill. and CHENNAI, India, Dec. ... HSP ), the world leader in ... Pharmaceuticals Ltd. (BSE: 524372, NSE: ORCHIDCHEM), a ... top-five generic beta-lactam antibiotics manufacturers globally, today ... Orchid,s generic injectable finished-dosage form pharmaceuticals business ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 2Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 3Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 4Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 2Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 3Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 4Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 5Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 6
... The 74 bulk drugs including some anti-allergy drugs and ... Drugs (Prices Control) order, 1995 (DPCO, 95) and the// ... prices are fixed/revised by the National Pharmaceutical Pricing Authority ... 95. In case there is any violation of approved/notified ...
... government has been investing millions of pounds into health ... conduct a massive survey to determine how// accessible the ... intended survey, patients are going to be endowed with ... to the doctor’s income. ,The Prime Minister during ...
... human testis harbors HIV-1 in resident immune cells, providing ... even after effective// highly active antiretroviral therapy (HAART). A ... testis to human immunodeficiency virus-1 infection in situ and ... American Journal of Pathology. ,According to ...
... look for a connection between brain activity thought to ... of the study will be published in the December ... ,Research findings show an asymmetry of activities in the ... pattern of asymmetry found is similar to that found ...
... or together – account for more than 20 percent of ... epidemiologist at Washington //University School of Medicine and corresponding author ... known to be 'gateway' drugs, that is, the overwhelming majority ... both of these legal drugs." ,Results of this ...
... is known to contain several ingredients with medicinal properties. ... confirmed// its possible lipid-lowering effects. ,This analysis ... RYR extract in changing lipid levels in people ... randomized controlled trials were conducted, in which 9625 participants ...
Other Medicine News:Health News:Britons soon will practise telling GPs how to practice 2Health News:A New Research Demonstrates HIV-1 In Resident Immune Cells Of Human Testis 2Health News:A New Research Explores Connection Between Emotionality And Alcoholism 2Health News:A New Research Explores Connection Between Emotionality And Alcoholism 3Health News:Adolescent Smokers Have Greater Vulnerability To AUDs Than Do Non-Smokers 2Health News:Adolescent Smokers Have Greater Vulnerability To AUDs Than Do Non-Smokers 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: